Clinical Trial Update: Efficacy and Safety in a Randomised Acute Pain Study of MR308: STARDOM2. [Phase 3]

View source ↗

Summary

Phase 3 randomized study update on efficacy and safety in acute pain (MR308) reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• MR308

Snippet

Sponsor: Mundipharma Research GmbH & Co KG | Conditions: Acute Pain | Phase 3 | Status: COMPLETED